Aug 7, 2024 4:30 pm EDT Capricor Therapeutics Second Quarter 2024 Financial Results and Corporate Update Conference Call
May 13, 2024 4:30 pm EDT Capricor Therapeutics First Quarter 2024 Financial Results and Corporate Update Conference Call
Mar 6, 2024 11:45 am EDT – 12:00 pm EDT 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Feb 29, 2024 4:30 pm EDT Capricor Therapeutics Fourth Quarter 2023 Financial Results and Corporate Update Conference Call
Nov 14, 2023 4:30 pm EDT Capricor Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call
Aug 7, 2023 4:30 pm EDT Capricor Therapeutic Second Quarter 2023 Financial Results and Corporate Update Conference Call
May 11, 2023 4:30 pm EDT Capricor Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call
Mar 15, 2023 4:30 pm EDT Capricor Therapeutics Fourth Quarter 2022 Financial Results and Corporate Update Conference Call
Nov 10, 2022 Capricor Therapeutics Third Quarter 2022 Financial Results and Corporate Update Conference Call
Oct 14, 2022 One-Year Results from HOPE-2 Open Label Extension Study Presented at World Muscle Society 2022 – Nova Scotia, Canada
Aug 10, 2022 Capricor Therapeutics Second Quarter 2022 Financial Results and Corporate Update Conference Call
Jun 22, 2021 Capricor Therapeutics Presentation at Parent Project Muscular Dystrophy (PPMD) 2021 Virtual Annual Conference
May 29, 2021 White House Chronicle, “Hurdles for innovative drug development at small biotech companies” featuring Capricor’s, CEO, Linda Marbàn
Aug 5, 2020 White House Chronicle, “Developing exosomal therapies for diseases” featuring Capricor’s ,CEO, Linda Marbàn